Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19009291)

  • 1. The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.
    Galustian C; Meyer B; Labarthe MC; Dredge K; Klaschka D; Henry J; Todryk S; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB; Dalgleish AG
    Cancer Immunol Immunother; 2009 Jul; 58(7):1033-45. PubMed ID: 19009291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of thalidomide and its analogues.
    De Sanctis JB; Mijares M; Suárez A; Compagnone R; Garmendia J; Moreno D; Salazar-Bookaman M
    Recent Pat Inflamm Allergy Drug Discov; 2010 Jun; 4(2):144-8. PubMed ID: 20307255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide.
    Henry JY; Labarthe MC; Meyer B; Dasgupta P; Dalgleish AG; Galustian C
    Immunology; 2013 Jul; 139(3):377-85. PubMed ID: 23374145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Thalidomide on the Expression of OX40, 4-1BB, and GITR in T Cell Subsets.
    Kim BS; Kim JY; Kim EJ; Lee JG; Joo DJ; Huh KH; Kim MS; Kim YS
    Transplant Proc; 2016 May; 48(4):1270-4. PubMed ID: 27320601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory properties of thalidomide analogs: pomalidomide and lenalidomide, experimental and therapeutic applications.
    Bodera P; Stankiewicz W
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Sep; 5(3):192-6. PubMed ID: 21913886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of thalidomide and its analogues: implications for anticancer therapy.
    Teo SK
    AAPS J; 2005 Mar; 7(1):E14-9. PubMed ID: 16146335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1.
    Savage ND; de Boer T; Walburg KV; Joosten SA; van Meijgaarden K; Geluk A; Ottenhoff TH
    J Immunol; 2008 Aug; 181(3):2220-6. PubMed ID: 18641362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity.
    Stroopinsky D; Avivi I; Rowe JM; Avigan D; Katz T
    Eur J Immunol; 2009 Oct; 39(10):2703-15. PubMed ID: 19634189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells in human autoimmune thyroid disease.
    Marazuela M; García-López MA; Figueroa-Vega N; de la Fuente H; Alvarado-Sánchez B; Monsiváis-Urenda A; Sánchez-Madrid F; González-Amaro R
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3639-46. PubMed ID: 16804051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of regulatory function by human CD8(+) T cells treated with anti-CD3 antibody requires TNF.
    Ablamunits V; Bisikirska B; Herold KC
    Eur J Immunol; 2010 Oct; 40(10):2891-901. PubMed ID: 21038470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo.
    Shao TY; Hsu LH; Chien CH; Chiang BL
    Sci Rep; 2016 Sep; 6():32415. PubMed ID: 27581189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
    Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple Myeloma.
    Pierceall WE; Amatangelo MD; Bahlis NJ; Siegel DS; Rahman A; Van Oekelen O; Neri P; Young M; Chung W; Serbina N; Parekh S; Agarwal A; Thakurta A
    Clin Cancer Res; 2020 Nov; 26(22):5895-5902. PubMed ID: 32928795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets.
    Kim EJ; Lee JG; Kim JY; Song SH; Joo DJ; Huh KH; Kim MS; Kim BS; Kim YS
    Immunology; 2017 Dec; 152(4):628-637. PubMed ID: 28758197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models.
    Cho SF; Lin L; Xing L; Li Y; Wen K; Yu T; Hsieh PA; Munshi N; Wahl J; Matthes K; Friedrich M; Arvedson T; Anderson KC; Tai YT
    Blood Adv; 2020 Sep; 4(17):4195-4207. PubMed ID: 32898244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model.
    Vo MC; Yang S; Jung SH; Chu TH; Lee HJ; Lakshmi TJ; Park HS; Kim HJ; Lee JJ
    Front Immunol; 2018; 9():1798. PubMed ID: 30123221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.
    Cohen AD; Schaer DA; Liu C; Li Y; Hirschhorn-Cymmerman D; Kim SC; Diab A; Rizzuto G; Duan F; Perales MA; Merghoub T; Houghton AN; Wolchok JD
    PLoS One; 2010 May; 5(5):e10436. PubMed ID: 20454651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.
    Lopez-Girona A; Mendy D; Ito T; Miller K; Gandhi AK; Kang J; Karasawa S; Carmel G; Jackson P; Abbasian M; Mahmoudi A; Cathers B; Rychak E; Gaidarova S; Chen R; Schafer PH; Handa H; Daniel TO; Evans JF; Chopra R
    Leukemia; 2012 Nov; 26(11):2326-35. PubMed ID: 22552008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
    Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
    Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.